Browsing by author "Jones, M."
Sort by:
Title A-Z
-
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial
McGree, J. M.; Hockham, C.; Kotwal, S.; Wilcox, A.; Bassi, A.; Pollock, C.; Burrell, L. M.; Snelling, T.; Jha, V.; Jardine, M.; Jones, M.Published 2021Summary The CLARITY trial (Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease) investigates the effectiveness of angiotensin receptor blockers in addition to standard care compared to ...Preprint -
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial
McGree, J.M.; Hockham, C.; Kotwal, S.; Wilcox, A.; Bassi, A.; Pollock, C.; Burrell, L.M.; Snelling, T.; Jha, V.; Jardine, M.; Jones, M.; for the CLARITY Trial Steering CommitteePublished 2022The CLARITY trial (Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease) is a two-arm, multi-centre, randomised controlled trial being run in India and Australia that investigates the ...Article -
Retrospective case-control study of 2017 g2p[4] rotavirus epidemic in rural and remote australia
Middleton, B.F.; Danchin, M.; Quinn, H.; Ralph, A.P.; Pingault, N.; Jones, M.; Estcourt, M.; Snelling, T.Published 2020Background: A widespread G2P[4] rotavirus epidemic in rural and remote Australia provided an opportunity to evaluate the performance of Rotarix and RotaTeq rotavirus vaccines, ten years after their incorporation into ...Article
Sort by:
Title A-Z